◂ Announcements

Mar 31, 2022CONTRACTDubai, UAE, United Arab Emirates

EOFlow signs 48.8B KRW supply deal for EOPatch insulin pump with Gulf Drug

EOFlow signed a contract with Gulf Drug of the UAE to supply 48.8 billion won ($40 million) worth of EOPatch wearable insulin pumps over five years. Gulf Drug will have exclusive sales rights in the GCC.

Value

$40.0M (48.8B KRW)

Status

Announced

ProductsEOPatch wearable insulin pump

CompaniesEOFlow Gulf Drug customer

Sectors#Medical Devices

“I am excited for EOFlow's additional market expansion in 2022 in the Middle East.”businesskorea.co.kr

1 source
businesskorea.co.krEOFlow to Supply KRW48.8bn Worth of EOPatch to Gulf Drug of UAE - BusinesskoreaChoi Moon-heeApr 4, 2022

Summarized from public sources; check the original articles before acting on it.

More from EOFlow

profile ▸

Dec 7, 2023ACQUISITION$738.0M
Medtronic scraps plans to buy EOFlow
Medtronic plc acquirer EOFlow target medtechdive.com
May 25, 2023ACQUISITIONSeongnam, South Korea, South Korea$738.0M
Medtronic to acquire wearable insulin patch maker EOFlow
Medtronic plc acquirer EOFlow target news.medtronic.com healthcare.levinassociates.com
Jun 3, 2022INVESTMENTGonjiam, South Korea$8.50Mops Dec 2022
Eoflow invests 10.85B won in Gonjiam plant for automated insulin patch production line
EOFlow medicaltimes.com
May 30, 2022EXPANSIONGonjiam, Gwangju, Gyeonggi Province, South Korea$8.70Mops Dec 2022
Eoflow invests KRW 10.85 billion in Gonjiam plant expansion and automation
EOFlow pharmnews.com
Oct 27, 2021INVESTMENTChangsha, China$7.90M
Sinocare invests USD7.9 million in EoFlow for diabetic sensor-pump JV
Sinocare EOFlow partner yicaiglobal.com
Sep 6, 2021INVESTMENTGwangju, Gyeonggi Province, South Korea$15.3M
Eoflow invests 18B won in Eopump production facility
EOFlow etoday.co.kr

Loading…

EOFlow signs 48.8B KRW supply deal for EOPatch insulin pump with Gulf Drug · Endata